Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

BACKGROUND: Patients suffering from high risk stage II colon cancer (CC) may benefit from adjuvant onco-therapy, but additional prognostic markers are needed for better treatment stratification. We investigated the prognostic value of Programmed Death Ligand-1 (PD-L1) in a true population-based coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksen, Ann C., Sørensen, Flemming B., Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373021/
https://www.ncbi.nlm.nih.gov/pubmed/30755167
http://dx.doi.org/10.1186/s12885-019-5345-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373021/
https://www.ncbi.nlm.nih.gov/pubmed/30755167
http://dx.doi.org/10.1186/s12885-019-5345-6

Ejemplares similares